Adams Chetwood Wealth Management’s Merck MRK Stock Holding History

Adams Chetwood Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$286K	Buy	3,481 +27	+0.8%	+$2.13K	0.16%	71
2021 Q4	$265K	Buy	+3,454	New	+$275K	0.18%	68

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Adams Chetwood Wealth Management's MRK Position: Q1 2022 in Review

Adams Chetwood Wealth Management increased its Merck (MRK) stake by 0.78% in Q1 2022, buying an estimated $2.13K and bringing the position to 3,481 shares worth $286K. The position accounts for 0.16% of the portfolio, ranked #71.

Adams Chetwood Wealth Management first reported a position in MRK in Q4 2021 and has held it in 2 quarters since. 2,953 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

Adams Chetwood Wealth Management held 3,481 shares of Merck worth $286K as of Q1 2022.
Adams Chetwood Wealth Management bought 27 Merck shares in Q1 2022, an estimated $2.13K.
Merck made up 0.16% of Adams Chetwood Wealth Management's portfolio in Q1 2022, its #71 holding.
Adams Chetwood Wealth Management first reported a position in Merck in Q4 2021 and has held it in 2 quarters since.
2,953 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Adams Chetwood Wealth Management's 13F filing for Q1 2022, filed 13 Apr 2022.